Maccura Biotechnology Co Ltd
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such a… Read more
Maccura Biotechnology Co Ltd (300463) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.023x
Based on the latest financial reports, Maccura Biotechnology Co Ltd (300463) has a cash flow conversion efficiency ratio of 0.023x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥148.82 Million) by net assets (CN¥6.38 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Maccura Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Maccura Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Maccura Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Maccura Biotechnology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TUHU Car Inc.
F:L83
|
N/A |
|
Guangdong Huate Gas Co Ltd
SHG:688268
|
0.046x |
|
Southern Missouri Bancorp Inc
NASDAQ:SMBC
|
0.029x |
|
Kornit Digital Ltd
NASDAQ:KRNT
|
0.015x |
|
Foshan Nationstar Optoelectronics Co Ltd
SHE:002449
|
0.024x |
|
Tianjin Printronics Circuit Corp
SHE:002134
|
0.067x |
|
Palfinger AG
PINK:PLFRF
|
0.205x |
|
Mandom Corporation
F:MD9
|
0.007x |
Annual Cash Flow Conversion Efficiency for Maccura Biotechnology Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Maccura Biotechnology Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.42 Billion | CN¥633.80 Million | 0.099x | -28.48% |
| 2023-12-31 | CN¥6.61 Billion | CN¥912.09 Million | 0.138x | +6.83% |
| 2022-12-31 | CN¥6.53 Billion | CN¥843.22 Million | 0.129x | -63.72% |
| 2021-12-31 | CN¥4.54 Billion | CN¥1.62 Billion | 0.356x | +30.32% |
| 2020-12-31 | CN¥4.01 Billion | CN¥1.09 Billion | 0.273x | +97.80% |
| 2019-12-31 | CN¥3.33 Billion | CN¥459.52 Million | 0.138x | +104.03% |
| 2018-12-31 | CN¥2.86 Billion | CN¥193.91 Million | 0.068x | +123.77% |
| 2017-12-31 | CN¥2.61 Billion | CN¥79.03 Million | 0.030x | +40.04% |
| 2016-12-31 | CN¥2.28 Billion | CN¥49.32 Million | 0.022x | +30.20% |
| 2015-12-31 | CN¥2.00 Billion | CN¥33.18 Million | 0.017x | -88.58% |
| 2014-12-31 | CN¥792.05 Million | CN¥115.09 Million | 0.145x | -10.73% |
| 2013-12-31 | CN¥604.48 Million | CN¥98.39 Million | 0.163x | -35.02% |
| 2012-12-31 | CN¥442.98 Million | CN¥110.96 Million | 0.250x | -8.71% |
| 2011-12-31 | CN¥311.77 Million | CN¥85.55 Million | 0.274x | -- |